Immupharma PLC TR-1 Notification of major holdings (6729P)
11 Junio 2020 - 6:00AM
UK Regulatory
TIDMIMM
RNS Number : 6729P
Immupharma PLC
11 June 2020
ImmuPharma PLC
("ImmuPharma" or the "Company")
Director/PDMR Shareholding
ImmuPharma (LSE:IMM) announces that on 11 June 2020, Dr Robert
Zimmer, a Director of the Company, transferred 20,000,000 ordinary
shares of 10 pence each ("Ordinary Shares") to Luca &
Associates AG, an entity connected with Dr Zimmer, and of which he
is President and a shareholder.
Following this transaction, Dr Zimmer remains interested in
27,344,514 Ordinary Shares as follows:
Shareholder Number of Ordinary % of issued share
Shares capital
Dr R Zimmer 4,551,553 2.49%
---------------------------------- --------------------
Mrs E Zimmer 792,961 0.43%
---------------------------------- --------------------
Luca & Associates AG 22,000,000 12.02%
---------------------------------- --------------------
Total 27,344,514 14.94%
---------------------------------- --------------------
For further information please contact:
ImmuPharma PLC ( www.immupharma.com )
Tim McCarthy, Chairman + 44 (0) 207 152 4080
Dimitri Dimitriou, Chief Executive Officer
Lisa Baderoon, Head of Investor Relations + 44 (0) 7721 413496
SPARK Advisory Partners Limited (NOMAD)
Neil Baldwin
Henry Todd
Stanford Capital Partners (Joint Broker)
Patrick Claridge, John Howes +44 (0) 203 368 3554
SI Capital (Joint Broker) +44 (0) 203 815 8880
Nick Emerson +44 (0) 1483 413500
4Reliance (Euronext Growth Listing Sponsor)
Jean-Charles Snoy
Degroof Petercam (Liquidity Provider)
Erik De Clippel
+32 (0) 2 747 02 60
Backstage Communication +32 (0) 2 287 95 34
Olivier Duquaine +32 (0) 477 504 784
Jean-Louis Dubrule +32 (0) 497 50 84 03
TR-1: S tandard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the ImmuPharma PLC
underlying issuer of existing shares
to which voting rights are attached
(ii) :
---------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
------------------
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
------------------
An acquisition or disposal of financial instruments
------------------
An event changing the breakdown of voting rights
------------------
Other (please specify)(iii) : Transfer of shares X
------------------
3. Details of person subject to the notification obligation (iv)
Name Luca & Associates AG
City and country of registered office
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name
---------------------------------------------------------
City and country of registered office
(if applicable)
---------------------------------------------------------
5. Date on which the threshold was 11 June 2020
crossed or reached (vi) :
---------------------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 11 June 2020
---------------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer (vii)
of 8. A) (total of 8.B
1 + 8.B 2)
----------------------- ------------------- ---------------- ------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 12.02% 12.02% 183,010,920
----------------------- ------------------- ---------------- ------------------
Position of
previous notification
(if
applicable)
----------------------- ------------------- ---------------- ------------------
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
-------------------------------------------
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
-------------------- --------------------- ---------------------------------- ---------------------
GB0033711010 22,000,000 12.02%
-------------------- --------------------- ---------------------------------- ---------------------
SUBTOTAL 8.
A 22,000,000 12.02%
------------------------------------------- ---------------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of Expiration Exercise/ Number of voting % of voting rights
financial date Conversion Period rights that may
instrument (x) (xi) be acquired if
the instrument
is
exercised/converted.
-------------------- --------------------- ---------------------------------- ---------------------
SUBTOTAL 8. B 1
--------------------- ---------------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to Art.
13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting rights
financial date (x) Conversion cash voting rights
instrument Period (xi) settlement
(xii)
--------------------- --------------------- --------------- -----------------
SUBTOTAL 8.B.2
--------------- -----------------
9. Information in relation to the person subject to the notification
obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer(xiii)
Full chain of controlled undertakings through which the voting rights X
and/or the financial instruments are effectively held starting with
the ultimate controlling natural person or legal entity(xiv) (please
add additional rows as necessary)
Name (xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is higher
is higher than the instruments if it than the notifiable
notifiable threshold equals or is higher threshold
than the notifiable
threshold
--------------------------- ------------------------ ------------------------
DR ZIMMER & OTHERS 2.92% 2.92%
--------------------------- ------------------------ ------------------------
LUCA & ASSOCIATES
AG 12.02% 12.02%
--------------------------- ------------------------ ------------------------
TOTAL 14.94 14.94
--------------------------- ------------------------ ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
--------------------------------------------------
The number and % of voting rights
held
--------------------------------------------------
The date until which the voting rights
will be held
--------------------------------------------------
11. Additional information (xvi)
The notification has arisen as Dr Zimmer has transferred 20,000,000 shares
to Luca & Associates AG, an entity connected with Dr Zimmer, and of which
he is President and a shareholder.
Place of completion 5, rue du Rhône 68100 Mulhouse France
Date of completion 11 June 2020
-------------------------------------------
TR-1: S tandard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the ImmuPharma PLC
underlying issuer of existing shares
to which voting rights are attached
(ii) :
---------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
------------------
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
------------------
An acquisition or disposal of financial instruments
------------------
An event changing the breakdown of voting rights
------------------
Other (please specify)(iii) : Transfer of shares X
------------------
3. Details of person subject to the notification obligation (iv)
Name Dr Robert Zimmer
City and country of registered office
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name
---------------------------------------------------------
City and country of registered office
(if applicable)
---------------------------------------------------------
5. Date on which the threshold was 11 June 2020
crossed or reached (vi) :
---------------------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 11 June 2020
---------------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer (vii)
of 8. A) (total of 8.B
1 + 8.B 2)
----------------------- ------------------- ---------------- ------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 14.94% 183,010,920
----------------------- ------------------- ---------------- ------------------
Position of
previous notification
(if
applicable)
----------------------- ------------------- ---------------- ------------------
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
-------------------------------------------
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
-------------------- --------------------- ---------------------------------- ---------------------
GB0033711010 5,344,514 22,000,000 2.92% 12.02%
-------------------- --------------------- ---------------------------------- ---------------------
SUBTOTAL 8.
A 27,344,514 14.94%
------------------------------------------- ---------------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of Expiration Exercise/ Number of voting % of voting rights
financial date Conversion Period rights that may
instrument (x) (xi) be acquired if
the instrument
is
exercised/converted.
-------------------- --------------------- ---------------------------------- ---------------------
SUBTOTAL 8. B 1
--------------------- ---------------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to Art.
13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting rights
financial date (x) Conversion cash voting rights
instrument Period (xi) settlement
(xii)
--------------------- --------------------- --------------- -----------------
SUBTOTAL 8.B.2
--------------- -----------------
9. Information in relation to the person subject to the notification
obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled x
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer(xiii)
Full chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held starting with
the ultimate controlling natural person or legal entity(xiv) (please
add additional rows as necessary)
Name (xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is higher
is higher than the instruments if it than the notifiable
notifiable threshold equals or is higher threshold
than the notifiable
threshold
-------------------------------- -------------------------- --------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
------------------------------------------------------
The number and % of voting rights
held
------------------------------------------------------
The date until which the voting rights
will be held
------------------------------------------------------
11. Additional information (xvi)
The notification has arisen as Dr Robert Zimmer has transferred 20,000,000
ordinary shares to Luca & Associates AG, an entity connected with Dr Robert
Zimmer, and of which he is President and a shareholder.
Included in Dr Zimmer's holding are 792,961 shares in the name of his
spouse Mrs Elizabeth Zimmer.
Place of completion 5, rue du Rhône 68100 Mulhouse France
Date of completion 11 June 2020
-------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
HOLEAPKFFLDEEEA
(END) Dow Jones Newswires
June 11, 2020 07:00 ET (11:00 GMT)
Immupharma (LSE:IMM)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Immupharma (LSE:IMM)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
